7 hasil untuk "Mathieu Vautier"

Apremilast in Refractory Behçet’s Syndrome: A Multicenter Observational Study

Matheus Vieira; Solène Buffier; Mathieu Vautier dkk.

Frontiers in Immunology, Vol. 11 · 2021 · Inggris · DOAJ Scopus

ObjectiveMucocutaneous and joint disorders are the most common manifestations in Behçet’s syndrome (BS) and are frequently clustered in the so-called minor forms of BS. There remains a need for safe and effective treatment for joint lesions in BS. We report the long-term safety and effectiveness of…

Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study

Adrien Mirouse; Antoine Parrot; Vincent Audigier dkk.

Critical Care, Vol. 24 No. 1 · 2020 · Inggris · DOAJ Scopus

Abstract Background Diffuse alveolar hemorrhage (DAH) occurs during the course of autoimmune disease and may be life threatening. The objective was to assess characteristics and prognosis factors of DAH who required intensive care unit (ICU) admission in patients with autoimmune diseases. Methods…

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19

Thierry Poynard; Olivier Deckmyn; Marika Rudler dkk.

PLOS ONE, Vol. 15 No. 11 · 2020 · Inggris · PLOS Scopus

Background: Since 1920, a decrease in serum cholesterol has been identified as a marker of severe pneumonia. We have assessed the performance of serum apolipoprotein-A1, the main transporter of HDL-cholesterol, to identify the early spread of coronavirus disease 2019 (Covid-19) in the general…

Juga tersedia di: DOAJ

Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial

Patrice Cacoub; David Ribes; Laurent Alric dkk.

Lupus Science and Medicine, Vol. 12 No. 1 · 2025 · Inggris · DOAJ Scopus

Objectives Some patients with SLE or Gougerot-Sjögren’s disease (GSD) receive long-term treatment with hydroxychloroquine (HCQ), sometimes combined with immunosuppressive therapy (IS). This study sought to assess whether long-term HCQ therapy that had been initiated long before the COVID-19…

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

Patrice Cacoub; Arsène Mekinian; David Saadoun dkk.

RMD Open, Vol. 9 No. 2 · 2023 · Inggris · DOAJ Scopus

Objectives In this large multicentre study, we compared the effectiveness and safety of tocilizumab intravenous versus subcutaneous (SC) in 109 Takayasu arteritis (TAK) patients.Methods We conducted a retrospective multicentre study in referral centres from France, Italy, Spain, Armenia, Israel…

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsResearch in context

Ilias I. Siempos; Andre C. Kalil; Drifa Belhadi dkk.

EClinicalMedicine, Vol. 69 · 2024 · Inggris · DOAJ Scopus

Summary: Background: Although immunomodulators have established benefit against the new coronavirus disease (COVID-19) in general, it is uncertain whether such agents improve outcomes without increasing the risk of secondary infections in the specific subgroup of previously immunocompromised…